1.08
3.57%
-0.04
시장 영업 전:
1.03
-0.05
-4.63%
Xilio Therapeutics Inc (XLO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
13.70%
17.36
|
20.12 | 23.53 | 23.17 | 20.21 |
Operating Income/Loss |
13.70%
-17.36
|
-20.12 | -23.53 | -23.17 | -20.21 |
Nonoperating Income/Loss |
19.45%
0.613
|
0.761 | 0.88 | 0.701 | 0.416 |
Income/Loss From Continuing Operations Before Tax |
13.47%
-16.75
|
-19.36 | -22.65 | -22.47 | -19.79 |
Income/Loss From Continuing Operations After Tax |
13.47%
-16.75
|
-19.36 | -22.65 | -22.47 | -19.79 |
Net Income/Loss
|
13.47%
-16.75
|
-19.36 | -22.65 | -22.47 | -19.79 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.20%
27.52
|
27.47 | 27.43 | 0.008 | 27.40 |
Basic Earnings Per Share |
12.86%
-0.61
|
-0.70 | -0.83 | -0.82 | -0.72 |
Diluted Earnings Per Share |
12.86%
-0.61
|
-0.70 | -0.83 | -0.82 | -0.72 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):